Translational control of gene expression during hypoxia

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Solid tumors frequently exhibit poor oxygenation (hypoxia), correlating with adverse patient prognosis.
• Hypoxia triggers adaptive cellular responses impacting gene expression and cell phenotype.
• Hypoxia-Inducible Factor (HIF) is central, driving genes for angiogenesis, metabolism, survival, and invasion.

Purpose of the Study:

• To investigate the mechanisms by which hypoxia suppresses protein synthesis.
• To elucidate the role of mRNA translation regulation in hypoxic gene expression.
• To understand how distinct pathways mediate translation inhibition under hypoxia.

Main Methods:

• Analysis of cellular responses to hypoxia.
• Investigation of protein synthesis regulation at the mRNA translation initiation step.
• Examination of the roles of the unfolded protein response (UPR), PERK, eukaryotic initiation factor 2alpha (eIF2alpha), eukaryotic initiation complex eIF4F, and mTOR kinase.

Main Results:

• Hypoxia suppresses protein synthesis through two distinct pathways.
• A rapid, transient pathway involves UPR and PERK-dependent eIF2alpha phosphorylation.
• A sustained pathway involves inhibition of the eIF4F complex, partly due to mTOR kinase inhibition.
• Differential mRNA translation efficiency, influenced by 5' and 3' UTR sequences, leads to variable gene-specific outcomes.

Conclusions:

• Regulation of mRNA translation is a critical mediator of gene expression during tumor hypoxia.
• Understanding these translation control mechanisms offers potential therapeutic targets.
• Hypoxia-induced translation suppression influences tumor progression and therapeutic resistance.